메뉴 건너뛰기




Volumn 101, Issue 8, 2004, Pages 1720-1732

Epoetin alfa improves quality of life in patients with cancer: Results of a metaanalysis

Author keywords

Anemia; Chemotherapy; Epoetin alfa; Metaanalysis; Quality of life

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

EID: 4744373395     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20569     Document Type: Review
Times cited : (80)

References (49)
  • 1
    • 0031814283 scopus 로고    scopus 로고
    • Update on the role of epoetin alfa in hematologic malignancies and myelodysplastic syndromes
    • Casadevall N. Update on the role of epoetin alfa in hematologic malignancies and myelodysplastic syndromes. Semin Oncol. 1998;25(3 Suppl 7):12-18.
    • (1998) Semin Oncol , vol.25 , Issue.3 SUPPL. 7 , pp. 12-18
    • Casadevall, N.1
  • 2
    • 0033989427 scopus 로고    scopus 로고
    • Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy
    • Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer. 2000;82:93-97.
    • (2000) Br J Cancer , vol.82 , pp. 93-97
    • Barrett-Lee, P.J.1    Bailey, N.P.2    O'Brien, M.E.3    Wager, E.4
  • 3
    • 0034533078 scopus 로고    scopus 로고
    • The impact and management of anaemia in haematological malignancies
    • Coiffier B. The impact and management of anaemia in haematological malignancies. Med Oncol. 2000;17(Suppl 1):S2-S10.
    • (2000) Med Oncol , vol.17 , Issue.SUPPL. 1
    • Coiffier, B.1
  • 4
    • 0038414196 scopus 로고    scopus 로고
    • European Cancer Anaemia Survey (EGAS): Prospective evaluation of anemia in over 15,000 cancer (CA) patients (pts)
    • Ludwig H, Birgegård G, Olmi P, Nortier J. European Cancer Anaemia Survey (EGAS): prospective evaluation of anemia in over 15,000 cancer (CA) patients (pts) [abstract]. Ann Oncol. 2002;13(Suppl 5);169.
    • (2002) Ann Oncol , vol.13 , Issue.SUPPL. 5 , pp. 169
    • Ludwig, H.1    Birgegård, G.2    Olmi, P.3    Nortier, J.4
  • 5
    • 0031842412 scopus 로고    scopus 로고
    • Factors influencing quality of life in cancer patients: Anemia and fatigue
    • Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol. 1998;25(3 Suppl 7):43-46.
    • (1998) Semin Oncol , vol.25 , Issue.3 SUPPL. 7 , pp. 43-46
    • Cella, D.1
  • 6
    • 0035400246 scopus 로고    scopus 로고
    • Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
    • Glaser CM, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys. 2001;50:705-715.
    • (2001) Int J Radiat Oncol Biol Phys , vol.50 , pp. 705-715
    • Glaser, C.M.1    Millesi, W.2    Kornek, G.V.3
  • 7
    • 0035367087 scopus 로고    scopus 로고
    • Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
    • Epoetin Alfa Study Group
    • Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. Epoetin Alfa Study Group. J Clin Oncol. 2001;19:2865-2874.
    • (2001) J Clin Oncol , vol.19 , pp. 2865-2874
    • Littlewood, T.J.1    Bajetta, E.2    Nortier, J.W.3    Vercammen, E.4    Rapoport, B.5
  • 8
    • 0034993236 scopus 로고    scopus 로고
    • Symptomatology of anemia
    • Ludwig H, Strasser K. Symptomatology of anemia. Semin Oncol. 2001;28(2 Suppl 8):7-14.
    • (2001) Semin Oncol , vol.28 , Issue.2 SUPPL. 8 , pp. 7-14
    • Ludwig, H.1    Strasser, K.2
  • 9
    • 0028068659 scopus 로고
    • Symptom problems, characteristics, and distress in a cancer population
    • Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom problems, characteristics, and distress in a cancer population. Qual Life Res. 1994;3:183-189.
    • (1994) Qual Life Res , vol.3 , pp. 183-189
    • Portenoy, R.K.1    Thaler, H.T.2    Kornblith, A.B.3
  • 10
    • 0030877720 scopus 로고    scopus 로고
    • Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey
    • The Fatigue Coalition
    • Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997;34(3 Suppl 2):4-12.
    • (1997) Semin Hematol , vol.34 , Issue.3 SUPPL. 2 , pp. 4-12
    • Vogelzang, N.J.1    Breitbart, W.2    Cella, D.3
  • 11
    • 0032190136 scopus 로고    scopus 로고
    • Fatigue in patients with cancer
    • Stone P, Richards M, Hardy J. Fatigue in patients with cancer. Eur J Cancer. 1998;34:1670-1676.
    • (1998) Eur J Cancer , vol.34 , pp. 1670-1676
    • Stone, P.1    Richards, M.2    Hardy, J.3
  • 12
    • 0033036612 scopus 로고    scopus 로고
    • Fatigue in cancer patients
    • Simon AM, Zittoun R. Fatigue in cancer patients. Curr Opin Oncol. 1999;11:244-249.
    • (1999) Curr Opin Oncol , vol.11 , pp. 244-249
    • Simon, A.M.1    Zittoun, R.2
  • 13
    • 0034097944 scopus 로고    scopus 로고
    • The impact of fatigue on patients with cancer: Overview of FATIGUE 1 and 2
    • Curt GA. The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist. 2000;5(Suppl 2):9-12.
    • (2000) Oncologist , vol.5 , Issue.SUPPL. 2 , pp. 9-12
    • Curt, G.A.1
  • 14
    • 0033807848 scopus 로고    scopus 로고
    • Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey
    • Cancer Fatigue Forum
    • Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000;11:971-975.
    • (2000) Ann Oncol , vol.11 , pp. 971-975
    • Stone, P.1    Richardson, A.2    Ream, E.3    Smith, A.G.4    Kerr, D.J.5    Kearney, N.6
  • 15
    • 0041464817 scopus 로고    scopus 로고
    • Assessment and management of cancer-related fatigue in adults
    • Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640-650.
    • (2003) Lancet , vol.362 , pp. 640-650
    • Ahlberg, K.1    Ekman, T.2    Gaston-Johansson, F.3    Mock, V.4
  • 16
    • 0141603243 scopus 로고
    • Fatigue and the cancer experience: The state of the knowledge
    • Winningham ML, Nail LM, Burke MB, et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum. 1994;21:23-36.
    • (1994) Oncol Nurs Forum , vol.21 , pp. 23-36
    • Winningham, M.L.1    Nail, L.M.2    Burke, M.B.3
  • 17
    • 0031843031 scopus 로고    scopus 로고
    • Anemia in cancer patients
    • Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol. 1998;25(3 Suppl 7):2-6.
    • (1998) Semin Oncol , vol.25 , Issue.3 SUPPL. 7 , pp. 2-6
    • Ludwig, H.1    Fritz, E.2
  • 18
    • 0032063729 scopus 로고    scopus 로고
    • The Schwartz Cancer Fatigue Scale: Testing and reliability
    • Schwartz AL. The Schwartz Cancer Fatigue Scale: testing and reliability. Oncol Nurs Forum. 1998;25:711-717.
    • (1998) Oncol Nurs Forum , vol.25 , pp. 711-717
    • Schwartz, A.L.1
  • 19
    • 0141770313 scopus 로고
    • Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus
    • Krantz SB, Goldwasser E. Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus. Proc Natl Acad Sci USA. 1984;81:7574-7578.
    • (1984) Proc Natl Acad Sci USA , vol.81 , pp. 7574-7578
    • Krantz, S.B.1    Goldwasser, E.2
  • 20
    • 0022484262 scopus 로고
    • Characterization and biological effects of recombinant human erythropoietin
    • Egrie JC, Strickland TW, Lane J, et al. Characterization and biological effects of recombinant human erythropoietin. Immunobiology. 1986;172:213-224.
    • (1986) Immunobiology , vol.172 , pp. 213-224
    • Egrie, J.C.1    Strickland, T.W.2    Lane, J.3
  • 21
    • 0023664340 scopus 로고
    • Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells
    • Sawyer ST, Krantz SB, Goldwasser E. Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J Biol Chem. 1987;262:5554-5562.
    • (1987) J Biol Chem , vol.262 , pp. 5554-5562
    • Sawyer, S.T.1    Krantz, S.B.2    Goldwasser, E.3
  • 23
    • 0025732160 scopus 로고
    • Erythropoietin is both a mitogen and a survival factor
    • Spivak JL, Pham T, Isaacs M, Hankins WD. Erythropoietin is both a mitogen and a survival factor. Blood. 1991;77:1228-1233.
    • (1991) Blood , vol.77 , pp. 1228-1233
    • Spivak, J.L.1    Pham, T.2    Isaacs, M.3    Hankins, W.D.4
  • 24
    • 0026535007 scopus 로고
    • Recombinant human erythropoietin in the treatment of the anaemia of cancer
    • Abels RI. Recombinant human erythropoietin in the treatment of the anaemia of cancer. Acta Haematol. 1992;87(Suppl 1):4-11.
    • (1992) Acta Haematol , vol.87 , Issue.SUPPL. 1 , pp. 4-11
    • Abels, R.I.1
  • 25
    • 0026736065 scopus 로고
    • Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer
    • Abels RI. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Semin Oncol. 1992;19(3 Suppl 8):29-35.
    • (1992) Semin Oncol , vol.19 , Issue.3 SUPPL. 8 , pp. 29-35
    • Abels, R.I.1
  • 26
    • 0031044609 scopus 로고    scopus 로고
    • Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
    • Procrit Study Group
    • Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997;15:1218-1234.
    • (1997) J Clin Oncol , vol.15 , pp. 1218-1234
    • Glaspy, J.1    Bukowski, R.2    Steinberg, D.3    Taylor, C.4    Tchekmedyian, S.5    Vadhan-Raj, S.6
  • 27
    • 0031785826 scopus 로고    scopus 로고
    • Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
    • Procrit Study Group
    • Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol. 1998;16:3412-3425.
    • (1998) J Clin Oncol , vol.16 , pp. 3412-3425
    • Demetri, G.D.1    Kris, M.2    Wade, J.3    Degos, L.4    Cella, D.5
  • 28
    • 0035366382 scopus 로고    scopus 로고
    • Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
    • Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol. 2001;19:2875-2882.
    • (2001) J Clin Oncol , vol.19 , pp. 2875-2882
    • Gabrilove, J.L.1    Cleeland, C.S.2    Livingston, R.B.3    Sarokhan, B.4    Winer, E.5    Einhorn, L.H.6
  • 29
    • 0034982679 scopus 로고    scopus 로고
    • The erythropoietin receptor
    • Mulcahy L. The erythropoietin receptor. Semin Oncol. 2001;28(2 Suppl 8):19-23.
    • (2001) Semin Oncol , vol.28 , Issue.2 SUPPL. 8 , pp. 19-23
    • Mulcahy, L.1
  • 30
    • 0027407786 scopus 로고
    • The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure
    • Cella D, Tulsky D, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
    • (1993) J Clin Oncol , vol.11 , pp. 570-579
    • Cella, D.1    Tulsky, D.2    Gray, G.3
  • 31
    • 20644459413 scopus 로고
    • Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
    • Zubrod CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960;11:7-33.
    • (1960) J Chron Dis , vol.11 , pp. 7-33
    • Zubrod, C.G.1    Schneiderman, M.2    Frei, E.3
  • 33
    • 0026877917 scopus 로고
    • The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
    • Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
    • (1992) Med Care , vol.30 , pp. 473-483
    • Ware, J.E.1    Sherbourne, C.D.2
  • 35
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple graphical test
    • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ. 1997;315:629-634.
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 36
    • 0027220373 scopus 로고
    • Erythropoietin for anemia in cancer patients
    • Abels R. Erythropoietin for anemia in cancer patients. Eur J Cancer. 1993;29A(Suppl 2):S2-S8.
    • (1993) Eur J Cancer , vol.29 A , Issue.SUPPL. 2
    • Abels, R.1
  • 37
    • 0027299160 scopus 로고
    • Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy
    • Case DC Jr., Bukowski RM, Carey RW, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst. 1993;85:801-806.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 801-806
    • Case Jr., D.C.1    Bukowski, R.M.2    Carey, R.W.3
  • 38
    • 0027239780 scopus 로고
    • Erythropoietin treatment of chronic anaemia of cancer
    • Ludwig H, Leitgeb C, Fritz E, et al. Erythropoietin treatment of chronic anaemia of cancer. Eur J Cancer. 1993;29A(Suppl 2):S8-S12.
    • (1993) Eur J Cancer , vol.29 A , Issue.SUPPL. 2
    • Ludwig, H.1    Leitgeb, C.2    Fritz, E.3
  • 39
    • 0027753073 scopus 로고
    • Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma
    • Ludwig H, Pecherstorfer M, Leitgeb C, Fritz E. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma. Stem Cells. 1993;11:348-355.
    • (1993) Stem Cells , vol.11 , pp. 348-355
    • Ludwig, H.1    Pecherstorfer, M.2    Leitgeb, C.3    Fritz, E.4
  • 40
    • 0002929285 scopus 로고
    • Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy
    • Henry DH, Brooks BJ Jr., Case DC Jr., et al. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am. 1995;1:252-260.
    • (1995) Cancer J Sci Am , vol.1 , pp. 252-260
    • Henry, D.H.1    Brooks Jr., B.J.2    Case Jr., D.C.3
  • 41
    • 0001390321 scopus 로고    scopus 로고
    • Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer
    • Abels RI, Larholt KM, Krantz KD, Bryant EC. Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer. Oncologist. 1996;1:140-150.
    • (1996) Oncologist , vol.1 , pp. 140-150
    • Abels, R.I.1    Larholt, K.M.2    Krantz, K.D.3    Bryant, E.C.4
  • 42
    • 14444276037 scopus 로고    scopus 로고
    • A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy
    • Pawlicki M, Jassem J, Bosze P, et al. A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy. Anticancer Drugs. 1997;8:949-957.
    • (1997) Anticancer Drugs , vol.8 , pp. 949-957
    • Pawlicki, M.1    Jassem, J.2    Bosze, P.3
  • 43
    • 0032927104 scopus 로고    scopus 로고
    • Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
    • Thatcher N, De Campos ES, Bell DR, et al. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer. 1999;80:396-402.
    • (1999) Br J Cancer , vol.80 , pp. 396-402
    • Thatcher, N.1    De Campos, E.S.2    Bell, D.R.3
  • 44
    • 0035021209 scopus 로고    scopus 로고
    • Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
    • Dammacco F, Castoldi G, Rodjer S. Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma. Br J Haematol. 2001;113:172-179.
    • (2001) Br J Haematol , vol.113 , pp. 172-179
    • Dammacco, F.1    Castoldi, G.2    Rodjer, S.3
  • 45
    • 0035503198 scopus 로고    scopus 로고
    • Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy
    • Canadian Eprex Oncology Study Group
    • Quirt I, Robeson C, Lau CY, et al. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. Canadian Eprex Oncology Study Group. J Clin Oncol. 2001;19:4126-4134.
    • (2001) J Clin Oncol , vol.19 , pp. 4126-4134
    • Quirt, I.1    Robeson, C.2    Lau, C.Y.3
  • 46
    • 4744345240 scopus 로고    scopus 로고
    • Early intervention with epoetin alfa treats anaemia and improves quality of life in ovarian cancer patients undergoing chemotherapy
    • Wilkinson PM, Andersson H, Antonopoulos M, Lahousen M. Early intervention with epoetin alfa treats anaemia and improves quality of life in ovarian cancer patients undergoing chemotherapy [abstract]. Eur J Cancer. 2001;37(6 Suppl):S264.
    • (2001) Eur J Cancer , vol.37 , Issue.6 SUPPL.
    • Wilkinson, P.M.1    Andersson, H.2    Antonopoulos, M.3    Lahousen, M.4
  • 47
    • 1642516679 scopus 로고    scopus 로고
    • Once weekly epoetin alfa maintains hemoglobin, improves quality of life and reduces transfusion in breast cancer patients receiving chemotherapy
    • Canadian Eprex Study Group [abstract]
    • Chang J, Couture F. Once weekly epoetin alfa maintains hemoglobin, improves quality of life and reduces transfusion in breast cancer patients receiving chemotherapy. Canadian Eprex Study Group [abstract]. Proc Am Soc Clin Oncol. 2003;22:727.
    • (2003) Proc Am Soc Clin Oncol , vol.22 , pp. 727
    • Chang, J.1    Couture, F.2
  • 48
    • 2142858255 scopus 로고    scopus 로고
    • Comparing the efficacy and safety of fixed vs weight-based dosing of epoetin alfa in anemic cancer patients receiving platinum-based chemotherapy
    • Granetto C, Ricci S, Martoni A, et al. Comparing the efficacy and safety of fixed vs weight-based dosing of epoetin alfa in anemic cancer patients receiving platinum-based chemotherapy. Oncol Rep. 2003;10:1289-1296.
    • (2003) Oncol Rep , vol.10 , pp. 1289-1296
    • Granetto, C.1    Ricci, S.2    Martoni, A.3
  • 49
    • 0036730276 scopus 로고    scopus 로고
    • Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence
    • Crawford J. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence. Oncology (Huntingt). 2002;16(9 Suppl 10):41-53.
    • (2002) Oncology (Huntingt) , vol.16 , Issue.9 SUPPL. 10 , pp. 41-53
    • Crawford, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.